Determination of specific glycobiomarkers in alpha-mannosidosis patients by NMR and mass spectrometry
Authors: |
Zuzana Pakanová 1
Mária Matulová 1
Marek Nemčovič 1
Filip Pančík 1
Filip Květoň 1
Iveta Uhliariková 1
Anna Šalingová 2
Anna Hlavatá 3
Ján Mucha 1
Peter Baráth 1
1 Institute of Chemistry, Slovak Academy of Sciences, Bratislava 2 National Institute of Children´s Diseases, Department of Laboratory Medicine, Bratislava 3 Comenius University, Faculty of Medicine and National Institute of Children´s Diseases, Department of Paediatrics, Bratislava |
---|---|
Year: | 2021 |
Section: | „Omics“ |
Abstract No.: | 2101 |
ISBN: | ISBN 978-80-972360-7-6 |
Alpha-mannosidosis is a progressive lysosomal storage disorder, firstly described in 1967[1]. It is caused by a partial or complete deficiency of alpha-mannosidose, enzyme playing an essential role in oligosaccharide and glycoprotein degradation. Mannose-rich oligosaccharides are accumulated in lysosomes of all tissues, resulting in impaired cellular function and apoptosis [2]. Due to the variability of clinical manifestation and multisystematic involvement, its definitive diagnostics may be challenging. MALDI TOF/TOF mass spectrometric analyses of permethylated oligosaccharides from urine of alpha-mannosidosis patients revealed characteristic set of specific mannose-based glycobiomarkers, compiled from Man2GlcNAc1 (m/z 722.3) up to Man8GlcNAc1 (m/z 1947.0). In 1H NMR spectra, characteristic signals of mannose units, originated from mannose in various linkages and locations in these oligosaccharides, as well as α,βGlcNAc from reducing ends were identified. Despite of non-quantitative nature of MALDI TOF/TOF analysis, 1H NMR was used for an overall quantification of mannose oligosaccharides. It is based on the integration of the signal, representing the core 1,3,6-linked βMan unit bound to the reducing end GlcNAc unit. Significantly increased intensities of 1,3-linked αMan signals in 1H NMR spectra confirmed results from mass spectrometry, suggesting Man2GlcNAc1 as the most abundant structure found in urine of alpha-mannosidosis patients. Presented methods were developed to become the basis for a precise monitoring of therapy efficacy in the future.
[2] Beck M, Olsen KJ, Wraith JE et al. (2013). Natural history of alpha-mannosidosis: a longitudinal study. Orphanet J Rare Dis.8:88.